Verserc 8 mg 30 tablets

Tradename

Verserk

Verserc

Composition

Each tablet contains:

betahistinedihydrochloride 8 mg or 16 mg or 24 mg.

Properties

Betahistine acts mainly on the histamine HI and H3 receptors of the inner ear and the vestibular nuclei of the central nervous system. It improves microcirculation and capillary permeability by direct agonistic effect on the HI receptors of the inner ear vessels, and also indirectly through the effect on H3 receptors, and normalizes endolymph pressure in the labyrinth and cochlea. However, betahistine increases blood flow in the basilar artery.

It has a pronounced central effect, being an inhibitor of the H3 receptors of the vestibular nerve nuclei. Improves the conductivity in the neurons of the vestibular nuclei at the level of the brain stem.

The clinical manifestation of these properti a decrease in the frequency and intensity of vertigo, a decrease in tinnitus, and an improvement in hearing in case of hearing loss.

Indications

-treatment and prevention of vestibular dizziness of various origins;

-Syndromes including dizziness and headache, tinnitus, progressive hearing loss, nausea and vomiting;

— disease or Meniere’s syndrome.

Side effects

Gastrointestinal disorders, the appearance of hypersensitivity reactions from the skin (rash,

itching, urticaria), Quincke’sedema

Storage method: